运动疗法可拯救心脏代谢性HFpEF的骨骼肌功能障碍和运动不耐受。

IF 8.4 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS JACC: Basic to Translational Science Pub Date : 2024-12-01 DOI:10.1016/j.jacbts.2024.07.009
Heather Quiriarte MS , Robert C. Noland PhD , James E. Stampley PhD , Gregory Davis MS , Zhen Li PhD , Eunhan Cho PhD , Youyoung Kim MS , Jake Doiron BS , Guillaume Spielmann PhD , Sujoy Ghosh PhD , Sanjiv J. Shah MD , Brian A. Irving PhD , David J. Lefer PhD , Timothy D. Allerton PhD
{"title":"运动疗法可拯救心脏代谢性HFpEF的骨骼肌功能障碍和运动不耐受。","authors":"Heather Quiriarte MS ,&nbsp;Robert C. Noland PhD ,&nbsp;James E. Stampley PhD ,&nbsp;Gregory Davis MS ,&nbsp;Zhen Li PhD ,&nbsp;Eunhan Cho PhD ,&nbsp;Youyoung Kim MS ,&nbsp;Jake Doiron BS ,&nbsp;Guillaume Spielmann PhD ,&nbsp;Sujoy Ghosh PhD ,&nbsp;Sanjiv J. Shah MD ,&nbsp;Brian A. Irving PhD ,&nbsp;David J. Lefer PhD ,&nbsp;Timothy D. Allerton PhD","doi":"10.1016/j.jacbts.2024.07.009","DOIUrl":null,"url":null,"abstract":"<div><div>Exercise intolerance, a hallmark of heart failure with preserved ejection fraction (HFpEF) exacerbated by obesity, involves unclear mechanisms related to skeletal muscle metabolism. In a “2-hit” model of HFpEF, we investigated the ability of exercise therapy (voluntary wheel running) to reverse skeletal muscle dysfunction and exercise intolerance. Using state-of-the-art metabolic cages and a multiomic approach, we demonstrate exercise can rescue dysfunctional skeletal muscle lipid and branched-chain amino acid oxidation and restore exercise capacity in mice with cardiometabolic HFpEF. These results underscore the importance of skeletal muscle metabolism to improve exercise intolerance in HFpEF.</div></div>","PeriodicalId":14831,"journal":{"name":"JACC: Basic to Translational Science","volume":"9 12","pages":"Pages 1409-1425"},"PeriodicalIF":8.4000,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11733766/pdf/","citationCount":"0","resultStr":"{\"title\":\"Exercise Therapy Rescues Skeletal Muscle Dysfunction and Exercise Intolerance in Cardiometabolic HFpEF\",\"authors\":\"Heather Quiriarte MS ,&nbsp;Robert C. Noland PhD ,&nbsp;James E. Stampley PhD ,&nbsp;Gregory Davis MS ,&nbsp;Zhen Li PhD ,&nbsp;Eunhan Cho PhD ,&nbsp;Youyoung Kim MS ,&nbsp;Jake Doiron BS ,&nbsp;Guillaume Spielmann PhD ,&nbsp;Sujoy Ghosh PhD ,&nbsp;Sanjiv J. Shah MD ,&nbsp;Brian A. Irving PhD ,&nbsp;David J. Lefer PhD ,&nbsp;Timothy D. Allerton PhD\",\"doi\":\"10.1016/j.jacbts.2024.07.009\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Exercise intolerance, a hallmark of heart failure with preserved ejection fraction (HFpEF) exacerbated by obesity, involves unclear mechanisms related to skeletal muscle metabolism. In a “2-hit” model of HFpEF, we investigated the ability of exercise therapy (voluntary wheel running) to reverse skeletal muscle dysfunction and exercise intolerance. Using state-of-the-art metabolic cages and a multiomic approach, we demonstrate exercise can rescue dysfunctional skeletal muscle lipid and branched-chain amino acid oxidation and restore exercise capacity in mice with cardiometabolic HFpEF. These results underscore the importance of skeletal muscle metabolism to improve exercise intolerance in HFpEF.</div></div>\",\"PeriodicalId\":14831,\"journal\":{\"name\":\"JACC: Basic to Translational Science\",\"volume\":\"9 12\",\"pages\":\"Pages 1409-1425\"},\"PeriodicalIF\":8.4000,\"publicationDate\":\"2024-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11733766/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JACC: Basic to Translational Science\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2452302X24002894\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JACC: Basic to Translational Science","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2452302X24002894","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

运动不耐受是因肥胖而加重的保留射血分数(HFpEF)心力衰竭的标志,其与骨骼肌代谢的相关机制尚不清楚。在HFpEF的“2-hit”模型中,我们研究了运动疗法(自主轮跑)逆转骨骼肌功能障碍和运动不耐受的能力。使用最先进的代谢笼和多组学方法,我们证明运动可以挽救功能失调的骨骼肌脂质和支链氨基酸氧化,并恢复心脏代谢性HFpEF小鼠的运动能力。这些结果强调了骨骼肌代谢对改善HFpEF运动不耐受的重要性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Exercise Therapy Rescues Skeletal Muscle Dysfunction and Exercise Intolerance in Cardiometabolic HFpEF
Exercise intolerance, a hallmark of heart failure with preserved ejection fraction (HFpEF) exacerbated by obesity, involves unclear mechanisms related to skeletal muscle metabolism. In a “2-hit” model of HFpEF, we investigated the ability of exercise therapy (voluntary wheel running) to reverse skeletal muscle dysfunction and exercise intolerance. Using state-of-the-art metabolic cages and a multiomic approach, we demonstrate exercise can rescue dysfunctional skeletal muscle lipid and branched-chain amino acid oxidation and restore exercise capacity in mice with cardiometabolic HFpEF. These results underscore the importance of skeletal muscle metabolism to improve exercise intolerance in HFpEF.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
JACC: Basic to Translational Science
JACC: Basic to Translational Science CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
14.20
自引率
1.00%
发文量
161
审稿时长
16 weeks
期刊介绍: JACC: Basic to Translational Science is an open access journal that is part of the renowned Journal of the American College of Cardiology (JACC). It focuses on advancing the field of Translational Cardiovascular Medicine and aims to accelerate the translation of new scientific discoveries into therapies that improve outcomes for patients with or at risk for Cardiovascular Disease. The journal covers thematic areas such as pre-clinical research, clinical trials, personalized medicine, novel drugs, devices, and biologics, proteomics, genomics, and metabolomics, as well as early phase clinical trial methodology.
期刊最新文献
When Facts Become Forbidden: The Past and Present History of Scientific Censorship. Editorial Board CircBTBD7-420aa Encoded by hsa_circ_0000563 Regulates the Progression of Atherosclerosis and Construction of circBTBD7-420aa Engineered Exosomes Translating Translation Impact of MEK Inhibition on Childhood RASopathy-Associated Hypertrophic Cardiomyopathy
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1